Nature's Sunshine Products, Inc. (NATR)

Over the past six months, Nature's Sunshine Products' stock has experienced significant appreciation, with an 81.22% increase. The share price increased by 111.42% from April 7, 2025, to April 2, 2026, but decreased by 14.09% in the most recent month. Key events include the relaunch of its "Revolutionary Power Line" on October 7, 2025, and the appointment of Kenneth Romanzi to the Board of Directors on October 29, 2025. On March 11, 2026, the company's full-year 2025 earnings reportedly missed analyst expectations, and earnings guidance for the full year 2026 was provided. An insider sold US$99k worth of stock on March 17, 2026. Recent news also mentioned a secondary public offering of common stock by Fosun Pharma USA, Inc., and a 400% increase in Q2 EPS.

Information regarding the specific demand seasonality for Nature's Sunshine Products, Inc. products and services was not available in the provided search results.

Nature's Sunshine Products, Inc. is a U.S.-based health and wellness company that develops, manufactures, and markets nutritional and herbal supplements, operating primarily in the dietary supplements, natural health, and personal wellness industries. The company distributes its products through a direct-selling model, and to a lesser extent, through retail and digital channels. Its major product lines encompass a wide range of nutritional and personal care items, including general health, immune support, cardiovascular, digestive, and personal care products, as well as weight management solutions, sold under the Nature's Sunshine and Synergy Worldwide brands.

Headquartered in Lehi, Utah, United States, Nature's Sunshine Products operates across multiple continents, maintaining a strong presence in North America, Asia, Europe, and Latin America. It distributes its products through a global direct sales force of over 500,000 active independent managers, distributors, and customers in more than 40 countries. The company's business is managed through geographic segments: Asia, Europe, North America, and Latin America/Other. Nature's Sunshine Products has manufacturing facilities in Utah and Chile and operates through various wholly-owned subsidiaries and local distribution networks internationally.

In the past year, Nature's Sunshine Products has demonstrated a commitment to its company culture and sustainability efforts. In December 2023, the company received several Comparably Awards, including "Best Company Culture," "Best Leadership Teams," "Best Company Work-Life Balance," and "Best Company Happiness." In April 2024, Nature's Sunshine released its 2023 Comprehensive Impact Report, highlighting advancements in sustainability across its sourcing, supply chain, and manufacturing processes. Key achievements included achieving TRUE GOLD Zero Waste Certification at U.S. distribution centers, reducing greenhouse gas emissions by 43% since 2022, moving to a four-day workweek at its manufacturing facility, and reducing virgin plastic use by over 500,000 pounds. The company also powers its Poland warehouse and distribution center with 100% wind energy. Historically, the company's U.S. sales experienced declines after peaking two decades ago, prompting a brand restaging process in 2018 to enhance its relevance and appeal to consumers. The company emphasizes science-based product development and regulatory compliance as part of its competitive positioning.

Nature's Sunshine Products, Inc. is a publicly traded company with a diverse ownership base comprising institutional investors, insiders, and public shareholders. Institutional investors hold a substantial portion of the company's stock, ranging from over 60% to approximately 83.62%. Major institutional shareholders include Wynnefield Capital Inc, Prescott Group Capital Management, L.l.c., and BlackRock, Inc. Insider ownership is approximately 8% to 8.94%, with Willem Mesdag noted as the largest individual shareholder. Eugene L. Hughes and Pauline Hughes are also listed as major individual owners. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. also holds a significant stake, which was recently reduced through a secondary offering.